Publications

Pepper JA, Vydelingum NA, Dunn BK, FagerstromRM: Agent-Based Models in Cancer Prevention Research; in Agent–Based Models: Theory, Developments & Applications – in Press.

Ankerst DP, Koniarski T, Liang Y, Leach RJ, Feng Z, Sanda MG, Partin AW, Chan DW, Kagan J, Sokoll L, Wei JT, Thompson IM. Updating risk prediction tools: a case study in prostate cancer. Biom J. 2012 Jan;54(1):127-42.
[ PubMed Abstract ]
Feng Z, Kagan J, Pepe M, Thornquist M, Rinaudo JA, Dahlgren J, Krueger K, Zheng Y, Patriotis C, Huang Y, Sorbara L, Thompson I, Srivastava S. The Early Detection Research Network's Specimen Reference Sets: Paving the Way for Rapid Evaluation of Potential Biomarkers. Clin Chem. 2012 Nov 27. [Epub ahead of print] PubMed PMID: 23193062.
[ PubMed Abstract ]
Kralj, Jason G, Arya, Chandamany, Tona, Alessandro, Forbes, Thomas P, Munson, Matthew S, Sorbara, Lynn, Srivastava, Sudhir and Forry, Samuel P. A simple packed bed device for antibody labelled rare cell capture from whole blood. Lab Chip, 2012, 12, 4972–4975.
[ PubMed Abstract ]
Liu T, Hossain M, Schepmoes AA, Fillmore TL, Sokoll LJ, Kronewitter SR, Izmirlian G, Shi T, Qian WJ, Leach RJ, Thompson IM, Chan DW, Smith RD, Kagan J, Srivastava S, Rodland KD, Camp DG 2nd. Analysis of serum total and free PSA using immunoaffinity depletion coupled to SRM: correlation with clinical immunoassay tests. J Proteomics. 2012 Aug 3;75(15):4747-57.
[ PubMed Abstract ]
Wagner PD, Srivastava S. New paradigms in translational science research in cancer biomarkers. Transl Res . 159:343-53, 2012.
[ PubMed Abstract ]

Cramer DW, Bast RC Jr, Berg CD, Diamandis EP, Godwin AK, Hartge P, Lokshin AE, Lu KH, McIntosh MW, Mor G, Patriotis C, Pinsky PF, Thornquist MD, Scholler N, Skates SJ, Sluss PM, Srivastava S, Ward DC, Zhang Z, Zhu CS, Urban N. Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens. Cancer Prev Res (Phila) 4(3):365-74, 2011.
[ PubMed Abstract ]
Zhu CS, Pinsky PF, Cramer DW, Ransohoff DF, Hartge P, Pfeiffer RM, Urban N, Mor G, Bast RC Jr, Moore LE, Lokshin AE, McIntosh MW, Skates SJ, Vitonis A, Zhang Z, Ward DC, Symanowski JT, Lomakin A, Fung ET, Sluss PM, Scholler N, Lu KH, Marrangoni AM, Patriotis C, Srivastava S, Buys SS, Berg CD. A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer. Cancer Prev Res (Phila) 4(3): 375-83, 2011.
[ PubMed Abstract ]

Atha DH, Manne U, Grizzle WE, Wagner PD, Srivastava S, Reipa V. Standards for Immunohistochemical Imaging: A protein reference device for biomarker quantitation. J Histochem and Cytochem. 58:1005-14, 2010.
[ PubMed Abstract ]
Baird CL, Fischer CJ, Pefaur NB, Miller KD, Kagan J, Srivastava S, Rodland KD. Developing recombinant antibodies for biomarker detection. Cancer Biomark. 2010;6(5-6):271-9.
[ PubMed Abstract ]
Dunn BK, Wagner PD, Anderson D, Greenwald P. Molecular Markers for Early Detection. Semin Oncol. 37:224-242, 2010.
[ PubMed Abstract ]
Patriotis, C., Maruvada, P. and Srivastava, S. Molecular Detection and Diagnosis of Cancer . In: The Molecular Basis of Human Cancer, 2 nd Edition. Humana Press. 2010.
Sokoll LJ, Sanda MG, Feng Z, Kagan J, Mizrahi IA, Broyles DL, Partin AW, Srivastava S, Thompson IM, Wei JT, Zhang Z, Chan DW. A prospective, multicenter, National Cancer Institute Early Detection Research Network study of [-2]proPSA: improving prostate cancer detection and correlating with cancer aggressiveness. Cancer Epidemiol Biomarkers Prev. 2010 May;19(5):1193-200.
[ PubMed Abstract ]
Wang W, Srivastava S. Strategic approach to validating methylated genes as biomarkers for breast cancer. Cancer Prev Res (Phila Pa). 2010;3(1):16-24. 136.
[ PubMed Abstract ]